Pharmacokinetics and Safety of BI 695501 in Healthy Subjects: a Randomized, Open-label, Single Dose, Parallel Arm, Active Comparator Clinical Phase I Study.

Trial Profile

Pharmacokinetics and Safety of BI 695501 in Healthy Subjects: a Randomized, Open-label, Single Dose, Parallel Arm, Active Comparator Clinical Phase I Study.

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Nov 2012

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Inflammatory bowel diseases; Psoriasis; Rheumatoid arthritis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 25 Jul 2012 Actual end date (Jul 2012) added as reported by ClinicalTrials.gov.
    • 25 Jul 2012 Actual patients number (193) added as reported by ClinicalTrials.gov.
    • 01 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top